RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

QIAGEN Deep Dive – Sample technologies

Home  >  Investor Relations  >  Events & Presentations  >  QIAGEN Deep Dive – Sample technologies

QIAGEN Deep Dive – Sample technologies

The third session in our QIAGEN Deep Dives series spotlighted QIAGEN’s Sample technologies – a cornerstone and driving force behind QIAGEN’s long-standing success.

The session offered an overview of the business, traced its evolution, highlighted what lies ahead, including three exciting new instrument launches and the acquisition of Parse Biosciences.

Watch the Sample technologies Deep Dive on-demand

Full event replay
DNA and RNA are everywhere – introduction
Insights into QIAGEN’s foundation and leadership in Sample technologies
Business perspectives, market updates and remarks on Parse Biosciences acquisition
The real-life impact of QIAGEN Sample technologies with customers and Thierry Bernard
Q&A

Speaker bios

Download all

Explore the full stories from our Sample tech Deep Dive

Parse’s strategic fit with QIAGEN Sample technologies

Learn more about Parse Biosciences, a fast-growing innovator in single-cell sample preparation. In this video, the company’s founders share what differentiates Parse in the single-cell market and explain how the acquisition by QIAGEN will help scale the business, accelerate innovation and create powerful synergies.



How QIAGEN‘s Sample tech supports justice: Julie Weil‘s story

Watch the full story of Julie Weil and learn how QIAGEN’s Sample technologies played a crucial role in identifying the perpetrator using the smallest amounts of evidence. This achievement highlights QIAGEN’s commitment to innovation that makes a real difference in forensics.

WARNING: This video recounts real-life experiences of a sexual assault survivor that some viewers may find distressing. Viewer discretion is advised.

Discover how Sample preparation enables our customers to advance science and improve healthcare

Liquid biopsy in cancer research

Hummingbird is driving innovation in cancer research by unlocking the potential of miRNAs. To ensure sample integrity and consistency, the team relies on QIAGEN’s Sample tech solutions. With QIAGEN, Hummingbird has been able to standardize and automate its workflows.

Studying Arctic microbes and climate change

The Nansen Legacy project in Norway preserves knowledge of the Barents Sea ecosystem as climate change transforms it. Microbial ecologist Dr. Stefan Thiele explains how QIAGEN’s Sample technologies enable reliable microbial analyses even in this challenging environment.

Securing the future of food supply

Scientists at Penn State College in the U.S. use QIAGEN’s DNA and RNA extraction solutions to advance microbiome research, driving improvements in food security, soil health and climate resilience. QIAGEN’s reliable offerings help standardize workflows – essential for successful plant microbiome manipulation.